SG11202002304YA - Biomarkers to detect and characterise cancer - Google Patents

Biomarkers to detect and characterise cancer

Info

Publication number
SG11202002304YA
SG11202002304YA SG11202002304YA SG11202002304YA SG11202002304YA SG 11202002304Y A SG11202002304Y A SG 11202002304YA SG 11202002304Y A SG11202002304Y A SG 11202002304YA SG 11202002304Y A SG11202002304Y A SG 11202002304YA SG 11202002304Y A SG11202002304Y A SG 11202002304YA
Authority
SG
Singapore
Prior art keywords
characterise
biomarkers
cancer
detect
characterise cancer
Prior art date
Application number
SG11202002304YA
Inventor
Frederic Bard
Zhi Hui Joanne Chia
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11202002304YA publication Critical patent/SG11202002304YA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202002304YA 2017-10-04 2018-10-04 Biomarkers to detect and characterise cancer SG11202002304YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201708183V 2017-10-04
PCT/SG2018/050502 WO2019070199A1 (en) 2017-10-04 2018-10-04 Biomarkers to detect and characterise cancer

Publications (1)

Publication Number Publication Date
SG11202002304YA true SG11202002304YA (en) 2020-04-29

Family

ID=65994629

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202002304YA SG11202002304YA (en) 2017-10-04 2018-10-04 Biomarkers to detect and characterise cancer

Country Status (5)

Country Link
US (1) US20200264186A1 (en)
EP (1) EP3692371A4 (en)
CN (1) CN111164428A (en)
SG (1) SG11202002304YA (en)
WO (1) WO2019070199A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020159445A1 (en) * 2019-01-31 2020-08-06 Agency For Science, Technology And Research Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
US11981729B2 (en) 2019-01-31 2024-05-14 Agency For Science, Technology And Research Method
WO2022157281A1 (en) * 2021-01-21 2022-07-28 Agency For Science, Technology And Research Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100475642B1 (en) * 2001-12-29 2005-03-10 한국생명공학연구원 A method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same
WO2008047370A2 (en) * 2006-10-19 2008-04-24 Ramot At Tel Aviv University Ltd. Compositions and methods for inducing angiogenesis
WO2009075883A2 (en) * 2007-12-12 2009-06-18 University Of Georgia Research Foundation, Inc. Glycoprotein cancer biomarker
US20140235494A1 (en) * 2011-09-21 2014-08-21 The Universify of North Carolina at Chapel Hill Methods, Kits and Computer Program Products using Hepatocellular Carcinoma (HCC) Biomarkers

Also Published As

Publication number Publication date
EP3692371A1 (en) 2020-08-12
EP3692371A4 (en) 2021-06-09
CN111164428A (en) 2020-05-15
US20200264186A1 (en) 2020-08-20
WO2019070199A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
ZA201908301B (en) Biomarkers and uses thereof
GB202008811D0 (en) Anomoly detection using cognitive computing
HRP20181566T1 (en) Cancer biomarkers and uses thereof
HK1245845B (en) Methods for detecting cpg methylation and for diagnosing cancer
SG11201607448PA (en) Determining cancer agressiveness, prognosis and responsiveness to treatment
HUE053281T2 (en) Cancer detection systems and methods
HK1231555A1 (en) Biomarker and uses thereof
HK1251171A1 (en) Tumor biomarkers and use thereof
EP3374524A4 (en) Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
HK1251927A1 (en) Novel biomarkers and methods of treating cancer
GB201609712D0 (en) Disease targets and biomarkers
HK1260327A1 (en) Methods of detecting cancer recurrence
GB201500584D0 (en) Cancer biomarkers
GB201602210D0 (en) Detection of cancer
SG11202002304YA (en) Biomarkers to detect and characterise cancer
IL244632A0 (en) Cancer biomarker and diagnostic
IL255351A0 (en) Astrocyte traumatome and neurotrauma biomarkers
EP3227687A4 (en) Dcis recurrence and invasive breast cancer
SG11201601234TA (en) Circulating cancer biomarker and its use
HK1231405A1 (en) Methods and compositions for screening and detecting cancer
GB201720851D0 (en) Device and methods to detect biomarkers using ologonucleotides
EP3201312A4 (en) Methods and devices relating to the detection of oral cancer biomarkers
GB201616640D0 (en) Monitoring cancer recurrence and progression
SG11201702077RA (en) Kit for cancer detection
ZA201708516B (en) Specific photoimmuno-theranostics for detection and elimination of skin cancer cells